Resting human CD4 T cells are highly resistant to transfection or infection with lentiviral vectors derived from the human immunodeficiency virus. We now describe a flexible and efficient approach involving virus-like particles containing simian immunodeficiency virus lentiviral gene product protein X and pseudotyping with CXCR4-tropic HIV Env. This method permits effective genetic manipulation of these cells while preserving their naturally quiescent state. This technology can also be extended to primary lymphoid cultures where authentic cellular composition and functional relationships are preserved.
INTRODUCTION

CD4 T cells play a central role in stimulating adaptive immune responses by interacting with various types of immune cells including B cells, cytotoxic T cells, macrophages and dendritic cells. Because of their key functions, enhanced CD4 T-cell activity
produced by genetic mutations, infection, or injury generates pathogenic responses characterized by chronic inflammation and hypersensitivity disorders. [1] [2] [3] Conversely, compromised CD4 T-cell function produces a profound state of immunodeficiency as exemplified by AIDS induced by HIV-mediated depletion of human CD4 T lymphocytes. 4 Blood has served as the most common source of CD4 T cells for the study of HIV infection because of the ease of access to this biological fluid. More recently, human lymphoid aggregate cultures (HLACs) derived from fresh tonsillar or splenic tissue have also been used for ex vivo analysis of CD4 T-cell function. 5 However, a critical limitation in the study of quiescent human CD4 T cells from either blood or lymphoid tissues is the lack of an experimental system that allows either the efficient knockdown of endogenous genes or the expression of exogenous genes in these cells. A number of viral and non-viral (synthetic) methods have been tested including antibody-targeted liposomes, 6 CD4 aptamer-siRNA chimeras, 7 electroporation such as nucleofection 8 and peptide transduction. 9 Nevertheless, these synthetic approaches have been hampered by low efficiency, direct cell toxicity, limited throughput, or the need for specialized laboratory equipment. Retroviral vectors, particularly those derived from lentiviruses such as HIV-1 and SIVmac251, are an alternative and more efficient strategy for gene delivery to lymphoid cells. 10 However, lentiviruses are critically limited in their ability to infect resting CD4 T cells in the peripheral blood and lymphoid tissues due to the expression of SAMHD1. 11 Through its phosphohydrolase activity, SAMHD1 decreases dexoxynucleotide triphosphate pools in quiescent CD4 T cells and greatly slows the kinetics of reverse transcription, often resulting in incomplete viral transcripts. [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] To relieve the SAMDH1-mediated resistance of primary CD4 T cells to HIV LV infection, we exploited the accessory lentiviral gene product protein X (Vpx) that induces polyubiquitylation and proteasomal degradation of SAMHD1 in non-permissive human myeloid 22 and resting CD4 T cells, 11 thereby alleviating the restriction block. Vpx is encoded by HIV-2 and its related simian immunodeficiency virus (SIV) strains, but not by HIV-1. Lentiviral vectors are also commonly pseudotyped with the vesicular stomatitis virus glycoprotein (VSV-G) 23 because of its broad viral tropism. However, in resting CD4 T cells, endocytosis is markedly limited rendering this envelope unsuitable for pseudotyping of lentiviral vectors. 24, 25 As the CXCR4 coreceptor for HIV is expressed on resting CD4 T cells, we have explored whether X4-tropic HIV Env can be used for pseudotyping to promote efficient entry of Vpx-containing viral-like particles and lentiviruses encoding various shRNAs into these cells without inducing overt cellular activation.
RESULTS AND DISCUSSION
Vpx molecules were incorporated into virus-like particles (VLPs) encoding the core packaging functions of SIVmac251 (Vpx-VLPs), as previously described. 26 These Vpx-VLPs are non-infectious, as they do not contain any viral genetic material, but they can be used to deliver Vpx into target cells where they promote degradation of SAMHD1, thereby rendering the cells permissive to HIV LV infection. 22 As noted, we pseudotyped the Vpx-VLPs with the CXCR4-tropic Env of HIV-1, which supports efficient fusion of viral particles to quiescent CD4 T lymphocytes. 24, 25 To silence the expression of select target genes in resting CD4 T cells, we used a third generation shRNA-encoding HIV LV vector pSico (plasmid for stable RNA interference, conditional), 27 bearing an EF1a:mCherry transgene expression cassette. These HIV LV particles were also pseudotyped with a CXCR4-tropic Env of HIV-1. To achieve productive infection of HIV LV particles, target cells were initially challenged with Vpx-VLPs, followed by a second infection with the HIV LV of interest 24 h later. This sequential infection strategy allowed Vpx to establish a permissive state within the target cells at the time when the HIV LV infection was performed. To facilitate a synchronized delivery of Vpx and fusion of HIV LV particles, cells and particles were subjected to highspeed spinoculation at each step ( Figure 1a ).
Using these experimental conditions, CD4 T cells were positively isolated from fresh human peripheral blood, tonsillar, or splenic Note that CD4 and NLRP3 expression were not reduced in mCherry-negative CD4 T cell populations. These data are representative of four independent experiments performed using CD4 T cells from peripheral blood, tonsil and spleen from four different donors.
tissues and spinoculated with Vpx-VLPs or empty virus-like particles, followed by infection with HIV LV particles encoding shRNA designed to silence the expression of the HIV receptor CD4 (shCD4) or the inflammasome protein NLRP3 (shNLRP3), versus a non-silencing control scrambled sequence (Scramble). Spinoculation of Vpx-VLPs efficiently abrogated SAMHD1 expression after 48 h in target CD4 T cells for all of the tissues analyzed. It was at this time that HIV LV infection was in progress (Figure 1b ). Of note, at longer times (96 and 120 h), endogenous SAMHD1 expression returned to normal levels, likely reflecting protein re-synthesis when cellular Vpx levels declined (Supplementary Figure 1) . After 4 days, the abundance of successful HIV LV infections was measured by flow cytometry on the basis of the number of CD4 T cells expressing the mCherry transgene. Spinoculation with VpxVLPs increased the number of mCherry-expressing CD4 T cells in all tested tissues (Figure 1c ). Such an increase was not observed in cultures spinoculated with empty VLPs. The background levels of mCherry expression in these cultures represent a small fraction of naturally 'primed' CD4 T cells that are permissive for HIV-1 infection. 12, 16, 28 Importantly, spinoculation with Vpx-VLPs did not lead to activation of resting CD4 T cells or cell death, as assessed by surface expression of the CD69 and CD25 activation markers and Annexin V (Supplementary Figure 2) . As previously reported, 29, 30 supplementation of the cultures with exogenous deoxynucleosides enhanced the shRNA lentiviral delivery to the target cells, but not as effectively as spinoculation with Vpx-VLPs (Supplementary Figure 3) . Thus, in agreement with a recent study, 31 the phosphohydrolase activity of SAMHD1 may not fully explain how SAMHD1 restricts HIV-1 infection. These results indicate that the loss of restriction to HIV LV infection was not due to non-specific cellular activation or cellular stress. Interestingly, the highest fold increase in HIV LV infection was observed in peripheral blood and spleen, corresponding to tissues where CD4 T cells exhibit particularly high resistance to lentiviral infection ( Figure 1d ).
We next examined the efficiency of gene silencing by HIV LV particles encoding shRNAs. For these experiments, peripheral blood CD4 T cells were spinoculated with Vpx-VLPs and infected with either shCD4 or Scramble HIV LV particles. After 4 days, flow cytometry analysis revealed a marked decrease in surface CD4 expression among mCherry-positive CD4 T cells infected with shCD4 HIV LV particles (Figure 1e ). Conversely, no decrease in CD4 expression was observed in either the mCherry-negative cells present in the same cultures or cells infected with Scramble HIV LV particles. These results indicate that the observed decrease in CD4 expression was due to shCD4-mediated silencing in the mCherrypositive cells. We next assessed gene silencing by shNLRP3 HIV LV particles introduced into tonsillar CD4 T cells. As with peripheral blood, a pronounced decrease in intracellular NLRP3 mRNA levels and protein expression were observed in the mCherry-positive subset of CD4 T cells following an infection with shNLRP3 HIV LV particles (Figure 1f ). These results suggest that efficient and specific genetic silencing can be achieved in resting CD4 T cells using Vpx-VLPs and shRNA-coding HIV LV particles. Importantly, the use of CXCR4-tropic HIV-1 Env allowed resting CD4 T cells to be selectively targeted for genetic silencing in fresh HLACs containing heterogeneous populations of lymphocytes, avoiding the need for prior CD4 T-cell purification (Supplementary Figure 4) .
We next assessed whether the genetic manipulations produced by HIV LV particles were sufficient to affect the biological responses occurring within these target cells. We first evaluated whether the infection of shCD4 HIV LV particles inhibits HIV-1 fusion into resting blood CD4 T cells. Remarkably, infections of shCD4, but not Scramble HIV LV particles, significantly reduced the level of HIV-1 fusion into mCherry-positive CD4 T cells (Figure 2a) . Interestingly, HIV-1 fusion was not inhibited in the mCherrynegative CD4 T cells within the same cultures (Figure 2b ), indicating that the observed inhibition was produced by the shCD4-encoding HIV LV. We next infected tonsillar CD4 T cells with shNLRP3 HIV LV particles and assessed their response to nigericin. As previously described, this potassium ionophore specifically promotes NLRP3 inflammasome formation, leading to caspase-1 activation and pyroptotic cell death. 32, 33 Treatment with nigericin induced marked activation of caspase-1 in cultures infected with scramble HIV LV, including mCherry-positive and -negative CD4 T cells. In contrast, nigericin treatment failed to induce caspase-1 activation in mCherry-positive CD4 T cells receiving the shNLRP3 HIV LV particles (Figure 2c) . Further, nigericin no longer induced pyroptotic cell death in these mCherry-positive CD4 T cells (Figure 2d, Supplementary Figure 5) .
Our studies describe an efficient lentivirus-based approach for manipulating gene expression in resting CD4 T cells. The use of CXCR4-tropic HIV-1 Env instead of vesicular stomatitis virusglycoprotein allows both selective and efficient fusion of lentiviral Figure 6) . 34, 35 The Vpx strategy has been powerfully employed for the introduction of HIV LV into cells of myeloid origin, 36, 37 but not in CD4 T cells from blood and lymphoid tissues, the principal targets of HIV-1. We believe this approach provides a valuable experimental tool to address key questions in the HIV field involving quiescent CD4 T cells abortively infected with the virus, including how DNA is detected in these cells 38 and the pathway through which these cells ultimately die. 33 It is also possible that this technology could be used to study aspects of HIV latency. 39 
MATERIALS AND METHODS
Expression plasmids
SIVmac251 VLPs for Vpx delivery (Vpx-VLPs) were produced using the pSIV3 þ plasmid, generously provided by Dr A Cimarelli. 40 The pSIV3 þ expression plasmid was constructed by replacing the 5 0 LTR of SIVmac251 with the CMV promoter and enhancer region. The 5 0 half of the env gene was also removed, leaving the REV-responsive element sequence and the 5 0 and 3 0 exons of the tat and rev regulatory genes intact. The 3 0 LTR was replaced by a SV40 polyadenylation sequence, resulting in deletion of the 3 0 end of the nef gene. Finally, the nef initiation codon was inactivated to prevent translation. 41 The detailed map of this construct is available at: http://www.retrovirology.com/content/5/1/50/figure/F1?highres=y. To produce empty VLPs, the vpx gene in the pSIV3 þ plasmid was inactivated by converting its initiation codon to a stop codon to give pSIV3 þ DVpx, generously provided by Dr Jacek Skowronski. 42 Different shRNAs were cloned into modified versions of the pSicoR lentiviral vector, which encodes a mCherry reporter driven by an EF-1a promoter (pSicoR-mCherry). 43 Production of Vpx-VLPs and shRNA-coding HIV LV particles VLPs and HIV-1 lentiviral particles were produced from 293T cells using the standard phosphate calcium transfection protocol. The medium was replaced after 16 h. After 48 h, the supernatants were collected and clarified by sedimentation, virions were concentrated by ultracentrifugation and stored at À 80 1C in 100% fetal bovine serum (FBS). For VLPs, 293T cells were transfected with 8 mg pSIV3 þ and 2 mg CXCR4-tropic Env (gp160) encoding plasmid (Vpx-VLPs) or with 8 mg PSIV3
þ DVpx and 2 mg gp160 (empty VLPs). The amount of VLPs was determined by measuring SIV p27 gag levels by enzyme-linked immunosorbent assay. shRNA-coding HIV-1 vectors were cloned using a modified version of the pSicoR (plasmid for stable RNA interference, conditional) lentiviral vector, 27 which encodes an mCherry reporter driven by an EF-1a promoter (pSicoR-mCherry). 43 For cloning of shCD4-coding HIV LV the following oligos were used: sense: 5 0 -TGATCAAGAGACTCCTCAGTTTCAAGAGAACTGAGGAGTCTCTTGATCTTTTT TC-3 0 ; antisense: 5 0 -TCGAGAAAAAAGATCAAGAGACTCCTCAGTTCTCTTGAAA CTGAGGAGTCTCTTGATCA-3 0 . For cloning of shNLRP3-coding HIV LV the following oligos were used: sense: 5 0 -TGAAATGGATTGAAGTGAAATTCAAGA GATTTCACTTCAATCCATTTCTTTTTTC-3 0 ; antisense: 5 0 -TCGAGAAAAAAGAAA TGGATTGAAGTGAAATCTCTTGAATTTCACTTCAATCCATTTCA-3 0 . To generate the shRNA HIV LV particles, 293T cells were co-transfected with 10 mg pSicoR-mCherry shRNA constructs, 9 mg HIV-based packaging construct NL4-3 8.91 44 and 2 mg gp160 encoding plasmids. The lentiviral particle stocks were quantitated by measuring p24 gag levels by enzyme-linked immunosorbent assay (1 ng p24 gag equals B2 Â 10 6 viral particles).
Culture of primary cells
Peripheral blood mononuclear cells from healthy blood donors (Blood Centers of the Pacific, San Francisco, CA, USA) were purified by Ficoll-Hypaque density gradients, followed by negative selection with CD14 þ microbeads or EasySep Human CD4 þ T Cell Enrichment Kit (Stemcell, Vancouver, BC, Canada) and positive selection with CD4 þ microbeads (Miltenyi, Bergisch Gladbach, Germany) (Supplementary Figure 7) . Purified resting CD4 þ T cells were cultured in RPMI 1640 medium supplemented with 10% FBS, L-glutamine (2 mM), penicillin (50 U ml
) and streptomycin (50 mg ml À 1 ). Human tonsil or spleen tissue was obtained from the National Disease Research Interchange and the Cooperative Human Tissue Network. HLACs were prepared using tonsillar or splenic tissue as previously described.
12,33,38 CD4 T cells were isolated from HLACs by positive selection using CD4 þ microbeads (Miltenyi Biotec Inc., San Diego, CA, USA) and cultured overnight in 96-well U-bottomed polystyrene plates (1 Â 10 6 cells per well) in medium (200 ml per well) consisting of RPMI 1640 supplemented with 15% heat-inactivated FBS, 100 mg ml À 1 gentamicin, 200 mg ml À 1 ampicillin, 1 mM sodium pyruvate, 1% nonessential amino acids (Mediatech, Manassas, VA, USA), 2 mM L-glutamine and 1% fungizone (Invitrogen, Indianapolis, IN, USA).
Two-step spinoculation procedure
Fresh CD4 T cells, HLACs, or peripheral blood lymphocytes were cultured in a V-bottom 96-well plate (1 Â 10 6 cells per well) and chilled on ice for 15 min. Vpx-VLPs pseudotyped with the CXCR4-tropic Env of HIV-1 were then added (100 ng p24 gag per 100 ml) to each well and mixed with cold cells for an additional 15 min. The cold temperature allows particle-cell attachment but prevents fusion. Particle-coated cells are then tightly packed into a pellet by high-speed centrifugation (1200 g) for 2 h at 4 1C. This step brings the viral particles in close apposition to the cell membranes, promoting a uniform and high level of attachment. Immediately after centrifugation, cells are cultured at 37 1C as a pellet. This step facilitates a coordinated fusion of the attached viruses, generating a pulse of virion entry into the target cells. After 24 h at 37 1C, Vpx-containing target cells are spinoculated again with shRNAcoding HIV LV particles coated with CXCR4-tropic Env of HIV-1, as described above. After 3 days of incubation, the cultures are analyzed. Of note, the enhancement by Vpx-VLPs using regular infection was not as effective as spinoculation (Supplementary Figure 6) . The background levels of mCherry expression in cultures without Vpx-VLPs enhancement represent a small fraction of naturally 'primed' CD4 T cells that are permissive for HIV LV infection, which can be blocked by reverse transcriptase inhibitor efavirenz (Supplementary Figure 8) . We observed a higher degree of productive infection using spinoculation at 4 1C followed by incubation at 37 1C, which generated a coordinated fusion of viral particles into the target cells. However, spinoculation at 37 1C was shown to enhance viral infection as well. FACS analysis and gating strategy CD4 T cells were washed in fluorescence-activated cell sorting (FACS) buffer (phosphate buffered saline supplemented with 2 mM EDTA and 2% FBS), stained with allophycocyanin-conjugated anti-CD4 or anti-CD25/CD69 (all from BD Biosciences, San Jose, CA, USA) and fixed in 1% paraformaldehyde. Data were collected on a FACS Calibur (BD Biosciences) and analyzed with Flowjo software (Treestar, San Carlos, CA, USA). The percentages of mCherry( þ ) CD4 T cells were defined on the basis of non-infected control samples. In some experiments, mCherry( þ ) CD4 T cells were purified by flow cytometry on a FACSAria II cell sorter (BD Biosciences). After cell sorting, 499% cells were found to be mCherry-positive.
Quantitative real-time RT-PCR Total RNA was purified from presorted mCherry( þ ) CD4 T cells with an RNeasy kit (Qiagen, Venlo, Netherlands). Purified RNA was Genetic manipulation of resting CD4 T cells by lentiviral vectors X Geng et al reverse-transcribed with Oligo(dT) 20 and the SuperScript III first-stand synthesis system (Invitrogen). Real-time PCR was performed with a QuantiTect Probe PCR kit (Qiagen) on a 7900HT fast real-time PCR system (Life Technologies, Grand Island, NY, USA). Thermal cycling consisted of 15 min denaturation at 95 1C, followed by 50 cycles of 15 s at 95 1C and 60 s at 60 1C. The data were normalized relative to GAPDH as an endogenous control. PCR assays were conducted with pre-developed TaqMan assay primers and probes (NLRP3: Hs00918082_m1; GAPDH: Hs03929097_g1; Life Technologies).
Intracellular NLRP3 staining
For fixation and antibody staining, tonsil CD4 T cells were seeded in a 96-well V-bottom plate at 1 Â 10 6 cells per 100 ml per well. Cells were fixed for 60 min at room temperature with 2% paraformaldehyde and permeabilized by washing twice in 1 Â BD Perm/Wash buffer (BD Biosciences, 554723). Cells were stained with DyLight 488-conjugated anti-NLRP3 antibody (1:20, Abcam, Cambridge, MA, USA; #ab139884) in 1 Â BD Perm/Wash buffer at 4 1C for 30 min in the dark. The staining was then monitored by flow cytometry.
Nigericin treatment, cell viability measurement and intracellular caspase-1 activation For stimulating the pyroptosis death pathway, tonsil CD4 T cells were treated with 5 mM nigericin (Sigma-Aldrich, Cat. # N7143) for 12 h at 37 1C. The potassium ionophore nigericin mediates an electroneutral exchange of intracellular K þ ions for extracellular protons, providing a second inflammatory stimulus, which results in the NLRP3-mediated activation of caspase-1. After 12 h, the cells were collected and assessed for cell viability and levels of caspase-1 activity. To determine the cell viability, a standard number of fluorescent beads (Flow-Count Fluorospheres, Beckman Coulter, Indianapolis, IN, USA) were added to each cell-suspension sample before data acquisition. The cell-suspension samples were analyzed using flow cytometry. The relative cell viability is normalized based on the number of fluorescent beads acquired. To determine the intracellular activation of caspase-1, Fluorescent Labeled Inhibitors of Caspases (FLICA) probe assays (ImmunoChemistry Technologies #9122, Bloomington, MN, USA) were performed. FLICA probes were added directly to the cell culture media, incubated for 15 min at 37 1C, and washed five times with phosphate buffered saline supplemented with 2 mM EDTA and 2% FBS. FLICA probes are cell-permeable and covalently bind to the active caspase-1. After washing, FLICA fluorescent signal is specifically retained within cells containing active caspase-1, whereas the reagent is washed away in cells lacking active caspase-1.
HIV virion-based fusion assay
The HIV virion-based fusion assay was performed as previously described. 45 Briefly, resting CD4 þ T cells (1 Â 10 6 ) were incubated with b-lactamase (BlaM)-Vpr containing virions (100 ng of p24gag) at 37 1C for 2 h, washed in CO 2 -independent medium (Life Technologies), and loaded with CCF2/AM dye as described by the manufacturer (Invitrogen). CCF2/ AM (1 mM; 2 ml) was mixed with 8 ml of 0.1% acetic acid containing 100 mg ml À 1 Pluronic-F127R and 1 ml of RPMI to constitute the loading solution. Cells were incubated in 100 ml of loading solution for 1 h at room temperature. After two washes with RPMI, the BlaM reaction was conducted for 16 h at room temperature in 200 ml of CO 2 -independent media supplemented with 10% FBS and 2.5 mM probenecid, a non-specific inhibitor of anion transport (Sigma-Aldrich). Finally, the cells were washed once in RPMI and fixed in a 2% solution of paraformaldehyde. The change in emission fluorescence of CCF2 after cleavage by the BlaM-Vpr chimera was monitored by flow cytometry with LSR2 (Becton Dickinson, San Jose, CA, USA). Data were collected with DiVa software and analyzed with FlowJo software (Treestar).
